Tomoaki Iwata

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Changes in Mutations of Cell-Free DNA and Liver Tumor Tissue in Patients with Advanced Hepatocellular Carcinoma before and after Introduction of Lenvatinib.

Changes in Mutations of Cell-Free DNA and Liver Tumor Tissue in Patients with Advanced Hepatocellular Carcinoma before and after Introduction of Lenvatinib.

Journal: Oncology

Published: March 10, 2024

Achieving diversity in the medical field:a survey of female physicians and medical staff in the Department of Gastroenterology

Achieving diversity in the medical field:a survey of female physicians and medical staff in the Department of Gastroenterology

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: September 10, 2023

Usefulness of the Fibrosis-4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients.

Usefulness of the Fibrosis-4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 10, 2023

Effectiveness of tacrolimus in a case of immune checkpoint inhibitor-induced hepatotoxicity that was refractory to steroids and mycophenolate mofetil.

Effectiveness of tacrolimus in a case of immune checkpoint inhibitor-induced hepatotoxicity that was refractory to steroids and mycophenolate mofetil.

Journal: Clinical journal of gastroenterology

Published: April 22, 2023

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage.

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage.

Journal: Scientific reports

Published: February 24, 2023

Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir.

Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir.

Journal: The Tohoku journal of experimental medicine

Published: October 16, 2022

Duodenal Variceal Rupture during Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma.

Duodenal Variceal Rupture during Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma.

Journal: Internal medicine (Tokyo, Japan)

Published: October 05, 2022

Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study.

Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study.

Journal: Medicine

Published: October 01, 2022

Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study.

Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study.

Journal: Journal of clinical medicine

Published: March 12, 2022

Reactivation of hepatitis C virus with severe hepatitis flare during steroid administration for interstitial pneumonia.

Reactivation of hepatitis C virus with severe hepatitis flare during steroid administration for interstitial pneumonia.

Journal: Clinical journal of gastroenterology

Published: March 02, 2021

Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2-Dependent Manner.

Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2-Dependent Manner.

Journal: Hepatology (Baltimore, Md.)

Published: October 12, 2020

Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation.

Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Case reports in gastroenterology

Published: October 08, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026